Which is why I pause when they say they're not looking for investor money – in medicine you'd at least have to phrase things in terms of "what already exists, and what's our contribution"? From that lens, I'm not sure what they're trying to contribute: instead of increasing the predictive value of full-body imaging, they're just making it cheaper?